Chemical firm Monsanto on Monday added a new lawsuit against it to a long list, as the city of Los Angeles said it was suing for intentionally polluting its water for decades with the family’s chemicals. PCB.
The city’s complaint, one of the largest in the United States, targets three companies including Bayer Group, a German giant that bought Monsanto in 2018 and is facing a series of legal actions around the world. For the insecticide round’up.
The lawsuit accuses Monsanto of polluting Los Angeles waterways with the release of PCBs (polychlorinated biphenyls) as far back as 1979.
These chemicals, which are toxic and have little to do with the environment, were used in paints, inks, paper or even as lubricants and sealants.
“It’s time for Monsanto to clean up and get paid,” said Los Angeles City Attorney Mike Feuer. “The health and environmental impact of PCBs – impacts that the city is working hard to reduce throughout Los Angeles – are simply jaw-dropping,” he insists.
“We claim that Monsanto knew for decades that PCBs were toxic and would inevitably cause widespread contamination (…) prosecutors.
The complaint states that exposure to PCBs can cause cancer, damage to the liver, thyroid and eyes, and even adversely affect growth.
The City of Los Angeles, which wants to receive financial compensation from Monsanto for water pollution, says the company had known about PCB’s toxicity to humans since the 1950s.
The complaint refers to three companies that were spun off from a division of Monsanto in the 1990s: The Monsanto Company, now owned by Bayer; Solutia, owned by Eastman Chemical Company, and Pharmacia acquired by Pfizer.
Neither of the three companies had responded on Monday afternoon.
Since its acquisition of Monsanto, Bayer has been undermined by a number of processes, collective and individual, that have been launched in relation to the insecticide Roundup and its active substance, glyphosate.
The German group disputes this characterization but the substance is classified as a “probable carcinogen” by the International Agency for Research on Cancer (IARC).
Bayer is also facing complaints from shareholders in Germany, who are claiming damages of at least 2.2 billion euros, alleging that they were sufficiently aware of the financial risks posed by these legal proceedings. has not been notified.
Analyst. Amateur problem solver. Wannabe internet expert. Coffee geek. Tv guru. Award-winning communicator. Food nerd.